OlleveCare vs Vytora Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
OlleveCare
Best for Maryland, DC, Virginia, and other listed-state buyers who want a small one-stop virtual-care storefront for GLP-1 weight loss combined with virtual urgent care and non-controlled refills, and who are comfortable starting a booking flow on IntakeQ without seeing pricing upfront. Acceptable fit only for buyers who already trust a Maryland-area solo virtual-care practice and prioritize the bundled urgent-care + GLP-1 model. NOT for buyers who require named-pharmacy disclosure, named medical director credentials, LegitScript verification, itemized dose-ladder pricing pre-purchase, defined refund terms, or any independent trust-signal verification — those buyers should look at WLR providers with explicit pharmacy/network disclosure (e.g., AVARA Rx with DiRx Health + Beluga Health, or Henry/Mochi/Found with disclosed clinical operations).Vytora Health
Best for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.Starting at $150/mo
Side-by-Side Comparison
| Feature | OlleveCare | Vytora Health |
|---|---|---|
| Overall Score | 4.2/10 | ✓8.7/10 |
| Starting Price | — | $150/mo |
| Editorial Rating | 2.1 ★ /5 | ✓4.4 ★ /5 |
| Features | 10 features | 10 features |
| States Available | 13 | ✓51 |
| Compounded | — | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
OlleveCare
Pros
- ✓13-state availability is enumerated verbatim on the homepage FAQ (VA, FL, AZ, MA, HI, IA, MD, NM, WA, KS, NY, DC, ID) — more transparent than DTC peers that say 'nationwide' without listing states
- ✓Both semaglutide and tirzepatide options surfaced for GLP-1 weight loss — buyers can switch molecules without switching platforms
- ✓Multi-service platform — GLP-1 + virtual urgent care + non-controlled refills lets a buyer consolidate primary-care-adjacent needs with one provider
- ✓Cash-pay with superbill option preserves the patient's ability to submit for out-of-network reimbursement
- ✓Founder/operator (Ahmed Emam) is identified by name in the footer linking to a personal Linktree — slightly above the fully-anonymous WordPress-storefront floor
- ✓Cancellation policy is disclosed: appointments canceled less than one hour before the visit or no-shows may incur a 'pre-disclosed non-refundable fee'
Cons
- ✗Operating legal entity name (LLC / PLLC / PA / Inc suffix) NOT disclosed anywhere on the site — only the brand 'OlleveCare' and individual operator 'Ahmed Emam' surface. Buyers cannot verify the legal entity in any state corporation registry.
- ✗Pricing NOT disclosed pre-booking — FAQ explicitly says 'You'll see the fee at the time of booking,' requiring the buyer to enter the IntakeQ flow before knowing the cost. No dose-ladder pricing for semaglutide (0.25mg/0.5mg/1mg/1.7mg/2.4mg) or tirzepatide (2.5mg/5mg/7.5mg/10mg/12.5mg/15mg).
- ✗Pharmacy partner NOT named — FAQ says 'prescriptions sent to your preferred pharmacy,' suggesting a fill-at-retail model rather than a named 503A compounding partnership. Buyers cannot verify the dispensing pharmacy's licensure or 503A/503B status.
- ✗Medical director / named prescribing clinician NOT disclosed by name. Only generic 'board-certified providers' and '10+ years of experience' language surfaces. MD/DO/NP/PA credential breakdown NOT specified.
- ✗LegitScript verification badge NOT displayed. BBB profile NOT found for OlleveCare or Gilead Express. SOC 2 and HIPAA-attestation seals NOT displayed.
- ✗Site is a single-page WordPress/Pagelayer/LiteSpeed build — /pricing, /about, /how-it-works, /faq, /services, /medical-weight-loss all return HTTP 404 (anchor-link nav only, no discrete pages). Suggests a small / early-stage operation rather than an established platform.
- ✗Lab-work requirements NOT specified — FAQ verbatim: 'If lab work is required, your provider will direct you on how to go about completing them,' with no baseline-labs-required, no Quest/Labcorp partnership, no panel disclosure.
- ✗Refund policy NOT surfaced beyond the late-cancellation fee — no medication-return policy, no provider-disqualifies refund, no satisfaction guarantee.
- ✗Branded GLP-1 options (Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, Rybelsus) NOT confirmed — semaglutide and tirzepatide are listed as molecules but the homepage does not clarify whether branded products are available or whether the model is compounded-only.
- ✗Form-factor breakdown NOT confirmed — injection is implied for semaglutide/tirzepatide but ODT, sublingual, troche, and oral options NOT confirmed.
Vytora Health
Pros
- ✓All 50 states + DC coverage with explicit per-state-modality compliance (video vs audio) disclosure
- ✓Both compounded AND brand-name options on a single platform — uncommon (most compounded-focused providers do not offer brand)
- ✓LegitScript Approved + HIPAA Compliant — both disclosed primary-source-verifiable
- ✓Pharmacy partners named publicly: Vials Pharmacy (TX) + Greenwich Biosciences — uncommon transparency
- ✓Owner / operating PC disclosed: Wasef Health, PC (Pinellas Park, FL)
- ✓Month-to-month pricing competitive ($180 sema / $249 tirz) and 3-month bundle (17% discount) for cost-sensitive patients
- ✓Brand-name Mounjaro and Zepbound available for patients who can self-pay $1,399/mo for FDA-approved options
- ✓Adjunct peptide offerings (NAD+, Sermorelin) for patients pursuing broader optimization regimens
Cons
- ✗Brand-name Mounjaro/Zepbound pricing ($1,399/mo) is near-retail; insured patients should pursue PA through traditional pharmacy + LillyDirect Self Pay Journey Program ($449-$699/mo) for better economics
- ✗Compounded tirzepatide tier ($249/mo) is above the lowest market floor ($149-199/mo) — Vytora pricing is mid-market for compounded
- ✗Specific dose-tier pricing not publicly broken out — pricing shown as 'all doses included' which is favorable but means high-dose patients pay the same as low-dose patients
- ✗Initial consultation cost not disclosed on public-facing pricing page (some providers free, some $99)
- ✗Limited primary-source-verifiable state licensure detail per individual prescriber (most multi-state telehealth platforms have this gap)
Our Verdict
Vytora Health edges out OlleveCare with a higher overall score of 8.7/10 and is particularly strong for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.. OlleveCare remains a solid alternative, especially if you're looking for Maryland, DC, Virginia, and other listed-state buyers who want a small one-stop virtual-care storefront for GLP-1 weight loss combined with virtual urgent care and non-controlled refills, and who are comfortable starting a booking flow on IntakeQ without seeing pricing upfront. Acceptable fit only for buyers who already trust a Maryland-area solo virtual-care practice and prioritize the bundled urgent-care + GLP-1 model. NOT for buyers who require named-pharmacy disclosure, named medical director credentials, LegitScript verification, itemized dose-ladder pricing pre-purchase, defined refund terms, or any independent trust-signal verification — those buyers should look at WLR providers with explicit pharmacy/network disclosure (e.g., AVARA Rx with DiRx Health + Beluga Health, or Henry/Mochi/Found with disclosed clinical operations)..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring OlleveCare and Vytora Health head-to-heads in the same category.
- OlleveCare vs CoreAge Rx
- OlleveCare vs TrimRx
- OlleveCare vs Amazon One Medical
- Vytora Health vs NovoCare Pharmacy
- Vytora Health vs Enhance MD
- Vytora Health vs Noom Med
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.